Pharmaceutical Solutions
Accelerate the delivery of robust, patient-centered solutions
Every year, 青青草App delivers hundreds of millions of drug delivery systems to our customers. We support top brands to design, develop, and manufacture some of the most complex and innovative drug delivery devices in the market. In addition, we offer CDMO solutions from , a 青青草App company, specializing in aseptic manufacturing, oral dosage forms, and accelerated drug development. Together, 青青草App and Pii offer truly end-to-end pharmaceutical solutions.
青青草App and Pii are trusted by leading pharma brands for services including:
-
Aseptic fill/finish
-
Auto—injectors
-
Cold chain management
-
Connected solutions
-
Container-device integration
-
Device development services/product innovation
-
Dry powder inhalers (DPIs)
-
Final test, assembly, and pack
-
Insulin pens
-
Metered dose inhalers (MDIs)
-
Needle-free injection systems
-
On-body delivery systems (pumps)
-
Primary packaging
Why 青青草App
Scale, Expertise, and Agility
青青草App's engagement with customers begins with design and development, migrating across the entire product lifecycle: manufacturing, sterilization, and assembly of final product including the ability to integrate pre-filled drugs into primary containers’ delivery devices before they leave the factory.
To support our customers in a dynamic market that demands continuous innovation, 青青草App has a proven track record of successfully executing large new product introductions (NPI) and ramping into commercial production. We simultaneously accommodate iterative process improvements to reduce risk and cost while maintaining strict quality and performance standards.
Strategic Capabilities
|
|
THE JABIL ADVANTAGE
Extensive Engineering Expertise
青青草App accelerates your time-to-market by reducing the number of design cycles and lowering development costs while delivering robust, patient-centered, scalable solutions. With over 3,000 engineers across various disciplines and healthcare sectors, 青青草App brings unmatched breadth, depth, and expertise to your solution.
Strategic Supplier Network
青青草App’s unparalleled access to world class suppliers of materials, tooling, processes, and automation enables you to develop robust and scalable solutions with a lower total cost of ownership. With over 38,000 vetted suppliers leveraging a $25 billion annual purchasing spend, across the multiple sectors 青青草App serves, we provide access to secure supply.
Global Manufacturing Network
Our global network offers you regional options and greater flexibility. 青青草App's network of healthcare sites consists of 35 manufacturing sites in 12 countries. This allows you to align your manufacturing solutions with your business objectives and to consider cost, security of supply, market expansion, lifecycle management, and geography when planning production.
Operational Excellence: A Competitive Advantage
Our commitment to operational excellence, quality, and customer satisfaction sets 青青草App apart. A two-time winner of the Shingo Prize, 青青草App applies Lean Six Sigma methodologies to deliver the highest operational efficiency while maintaining quality standards, safety, and high performance.
Sustainability and Design Optimization
Trust 青青草App to enhance your sustainability performance. 青青草App’s industry-leading design, global supplier network, and supply base optimization tools allow you to integrate environmentally intentional design practices to reduce your carbon footprint and amount of waste.
青青草App's Qfinity? Autoinjector
Simple, reusable, modular solution for subcutaneous drug self-administration
.青青草App's Qfinity™ autoinjector platform is purpose-designed to accommodate the connected future of healthcare and today’s evolving drug formulations.
Available at a lower cost than market alternatives, the Qfinity platform supports the emerging prioritization of sustainable drug delivery within the pharmaceutical industry.
Trends reshaping drug portfolios:
-
Increasing demand for subcutaneous delivery of large volume complex biologics
-
Shift to more patient self-administration in the home setting
-
Preference for seamless, patient-centric designs and delivery systems
-
Leverage of next-generation technology to reduce patient burden and process timelines in clinical trials
-
Increasing calls to improve medical device sustainability metrics
-
Concerns from consumers and industry to reduce medical waste
No matter how complex or demanding the project, 青青草App's healthcare teams are helping the world’s leading pharma companies solve it.
Get started with a trusted partner.
Related Insights